Cancer Stem Cell News Volume 2.10 | Mar 13 2013


    Cancer Stem Cell News 2.10 March 13, 2013
         In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
    Cell Therapy News on Facebook  Cancer Stem Cell News on Twitter

    Transient Treatment with Epigenetic Modifiers Yields Stable Neuroblastoma Stem Cells Resembling Aggressive Large-Cell Neuroblastomas
    By treating neuroblastoma (NB) cell lines [SKNAS, SKNBE(2)C, CHP134, and SY5Y] with epigenetic modifiers for a short time, followed by sphere-forming culture conditions, researchers established stem cell-like NB cells that are phenotypically stable for more than a year. [Proc Natl Acad Sci USA]
    Abstract | Full Article

    Watch the Video: Optimize Your ALDHbr Cell Detection with Tissue-Specific ALDEFLUOR™ Protocols

    PUBLICATIONS (Ranked by impact factor of the journal)

    Sox2 Cooperates with Inflammation-Mediated Stat3 Activation in the Malignant Transformation of Foregut Basal Progenitor Cells
    Scientists used mouse genetic models to reveal a mechanism by which Sox2 cooperates with microenvironmental signals to malignantly transform epithelial progenitor cells. Their findings indicated that basal stem/progenitor cells are the cells of origin of squamous carcinoma and that cooperation between Sox2 and microenvironment-activated Stat3 is required for Sox2-driven tumorigenesis. [Cell Stem Cell] Abstract | Graphical Abstract

    Differential Expression Profiles of Glycosphingolipids in Human Breast Cancer Stem Cells vs. Cancer Non-Stem Cells
    Researchers analyzed glycosphingolipids expressed in human breast cancer stem cells (CSCs) by applying a CSC model induced through epithelial-mesenchymal transition, using mass spectrometry, TLC immunostaining, and cell staining. [Proc Natl Acad Sci USA] Abstract

    Canonical and Non-Canonical NF-κB Signaling Promotes Breast Cancer Tumor-Initiating Cells
    Investigators explored the potential involvement of the nuclear factor-κB (NF-κB) family of transcription factors in tumor-initiating cells in cell lines that are representative of basal-like and claudin-low breast cancer. [Oncogene] Abstract

    An Endogenous Inhibitor of Angiogenesis Inversely Correlates with Side Population Phenotype and Function in Human Lung Cancer Cells
    The side population (SP) in human lung cancer cell lines and tumors is enriched with cancer stem cells. Here researchers examined the hypothesis that tissue inhibitor of matrix metalloproteinase-2 antitumor activity may involve regulation of the SP in human lung cancer cells. [Oncogene] Abstract

    Estrogen Increases the Activity of Estrogen Receptor-Negative Breast Cancer Stem Cells through Paracrine EGFR and Notch Signaling
    Scientists tested the effects of estrogen on cancer stem cell activity in vitro and in vivo and investigated which paracrine signaling pathways locally mediate estrogen effects. [Breast Cancer Res]
    Abstract | Full Article

    Identification and Characterization of Cells with Cancer Stem Cell Properties in Human Primary Lung Cancer Cell Lines
    Results indicated that CD44highCD90+ sub-population may represent cancer stem cells (CSCs) in small cell lung cancer and large cell carcinoma, whereas in squamous cell carcinoma lung cancer subtype, CSC potentials were found within the CD44high sub-population. [PLoS One] Full Article

    Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) Plays a Key Role in Vasculogenic Mimicry Formation, Neovascularization and Tumor Initiation by Glioma Stem-Like Cells
    The authors report a critical role of glioma stem-like cells (GSLCs) in the formation of vasculogenic mimicry (VM), which defines channels lined by tumor cells to supply nutrients to early growing tumors and tumor initiation. GSLCs preferentially expressed VEGFR-2 that upon activation by VEGF, mediated chemotaxis, tubule formation and increased expression of critical VM markers by GSLCs. [PLoS One] Full Article

    Tumor-Infiltrating Immune Cells: Triggers for Tumor Capsule Disruption and Tumor Progression?
    Aberrant immune cell infiltration may have the same destructive impact on the capsule of all epithelium-derived tumors. This, in turn, may selectively favor the proliferation of tumor stem or progenitor cells overlying these focal disruptions. These proliferating epithelial tumor cells subsequently disseminate from the focal disruption leading to tumor invasion and metastasis. [Int J Med Sci] Full Article

    NeuroCult™ for Brain Tumor Research - View Publications

    Cancer Stem Cell Theory: Therapeutic Implications for Nanomedicine
    The authors highlight the mechanisms of drug resistance and the novel strategies using nanoscale drugs to eliminate cancer stem cells. [Int J Nanomedicine] Abstract | Full Article


    OncoMed Pharmaceuticals Initiates Phase I Clinical Trial of Anti-Cancer Stem Cell Therapeutic OMP-52M51 (Anti-Notch1) in Solid Tumors
    OncoMed Pharmaceuticals, Inc. announced that patient dosing has begun in a Phase I clinical trial of OMP-52M51 in patients with advanced, refractory solid tumors. [OncoMed Pharmaceuticals, Inc.] Press Release

    Roche Obtains EU Approval for PERJETA, a New Personalized Treatment for Aggressive Type of Breast Cancer
    Roche announced that the European Medicines Agency has approved PERJETA for patients with previously untreated HER2-positive metastatic breast cancer. PERJETA is approved in combination with Herceptin and docetaxel in adult patients with HER2-positive metastatic or locally recurrent unresectable breast cancer, who have not received previous anti-HER2 therapy or chemotherapy for their metastatic disease. [F. Hoffman-La Roche Ltd] Press Release

    National Institutes of Health (United States)

    Food and Drug Administration (United States)

    Center for Biologics Evaluation and Research (United States)

    European Medicines Agency (European Union)

    Medicines and Healthcare Products Regulatory Agency (United Kingdom)

    Therapeutic Goods Administration (Australia)

    NEW BioTherapeutics 2013
    May 14-17, 2013
    Stevenage, United Kingdom

    our events page to see a complete list of events in the cancer stem cell community.


    Faculties in Cancer Biology & Immunotherapy (Huzhou University School of Medicine)

    Postdoctoral Scientist (Eli Lilly)

    Postdoctoral Position (University of Kentucky College of Medicine)

    PhD Studentship Opportunity (University of East Anglia)

    Postdoctoral Fellow – Epigenetics (Structural Genomics Consortium at University of Toronto)

    Postdoctoral Fellowship – Hematopoietic and Leukemia Stem Cells (Cincinnati Children’s Hospital and Medical Center)

    PhD Student (Universitätsklinikum Carl Gustav Carus)

    PhD Studentship – Signal Transduction and Cancer Research (Department of Medicine, McGill University)

    Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

    Have we missed an important article or publication in Cancer Stem Cell News? Click here to submit!

    Comments or Suggestions? Email with your feedback.

    Learn more about Cancer Stem Cell News: Archives | Events | Contact Us